138
S. Demir et al. / Journal of Organometallic Chemistry 755 (2014) 134e140
spectra were recorded with a Varian AS 400 Merkur spectrometer
operating at 400 MHz (1H), 100 MHz (13C) in CDCl3 with tetra-
methylsilane as an internal reference. Coupling constants (J values)
are given in hertz. NMR multiplicities are abbreviated as follows:
4.2.1.5. N-(Methylcyclobutane)benzimidazole, L5. Yield:1.66g(89%).
FT-IR y(CN): 1493 cmꢁ1, m.p.: 63e64 ꢀC. Anal. Calc. for C12H14N2: C,
77.38; H, 7.58; N, 15.04. Found: C, 77.35; H, 7.54; N: 15.01%. 1H NMR
(399.9 MHz, CDCl3)
d
(ppm) ¼ 7.93 (s, 1H, NCHN), 7.85e7.79 (m, 1H,
s
¼
singlet,
d
¼
doublet,
t
¼
triplet, hept
¼
heptet, and
NC6H4N), 7.44e7.39 (m, 1H, NC6H4N), 7.35e7.26 (m, 2H, NC6H4N), 4.17
(d, 2H, J ¼ 7.2 Hz, CH2CH(CH2)2CH2), 2.89 (hept., 1H, J ¼ 7.5 Hz,
CH2CH(CH2)2CH2), 2.13e2.03 (m, 2H, CH2CH(CH2)2CH2), 2.00e1.76
(m, 4H, CH2CH(CH2)2CH2). 13C NMR (100.5 MHz, CDCl3)
m ¼ multiplet signal. All catalytic reactions were monitored on an
Agilent 6890N GC system by GC-FID with an HP-5 column of 30 m
length, 0.32 mm diameter and 0.25
mm film thickness. Column
chromatography was performed using silica gel 60 (70e
230 mesh). Solvent ratios are given as v/v.
d
(ppm) ¼ 144.3 (NCHN), 143.9, 134.5, 122.7, 121.8, 119.9, 110.9
(NC6H4N), 49.4 (CH2CH(CH2)2CH2), 35.4 (CH2CH(CH2)2CH2), 25.7
(CH2CH(CH2)2CH2), 18.0 (CH2CH(CH2)2CH2).
4.2. Synthesis and characterization of 1-alkylbenzimidazole ligand
(L1eL6)
4.2.1.6. N-(2-Ethylbutane)benzimidazole, L6. Yield: 1.64 g (81%). FT-
IR y(CN): 1456 cmꢁ1, m.p.: 44e45 ꢀC. Anal. Calc. for C13H18N2: C, 77.18;
H, 8.97; N, 13.85. Found: C, 77.15; H, 8.94; N: 13.81%. 1H NMR
4.2.1. General procedure for the preparation of the 1-
alkylbenzimidazole
(399.9 MHz, CDCl3)
d
(ppm) ¼ 8.22 (s, 1H, NCHN), 7.66e7.55 (m, 2H,
Benzimidazole (10 mol) was added to a solution of NaH
(10 mol) in dry THF (30 mL), the mixture was stirred for 1 h at
room temperature, and the corresponding alkyl halides (10.1 mol)
was added dropwise and heated for 8 h. The solvent was removed
in vacuum, after that dichloromethane (50 mL) was added in the
Schlenk tube. The mixture was filtered and then the salt was
separated from solution. The solution was concentrated and
diethyl ether was added. The colorless product was obtained as a
crystal.
NC6H4N), 7.27e7.17 (m, 2H, NC6H4N), 4.13 (d, 2H, J ¼ 7.25 Hz,
CH2CH(CH2CH3)2, 1.83(hept., 1H, J ¼ 6.75 Hz, CH2CH(CH2CH3)2), 1.25
(p, 4H, J ¼ 7.5 Hz, CH2CH(CH2CH3)2), 0.86 (t, 6H, J ¼ 6.9 Hz,
CH2CH(CH2CH3)2). 13C NMR (100.5 MHz, CDCl3)
d
(ppm) ¼ 144.9
(NCHN), 143.9, 134.5, 122.7, 121.8, 119.9, 110.9 (NC6H4N), 47.9
(CH2CH(CH2CH3)2), 39.2 (CH2CH(CH2CH3)2), 23.2 (CH2CH(CH2CH3)2),
10.8 (CH2CH(CH2CH3)2).
4.3. Synthesis and characterization of the half sandwich
ruthenium(II) complexes (1e6)
4.2.1.1. N-(3,4-Dichlorobenzyl)benzimidazole, L1. Yield: 2.55
(92%). FT-IR y(CN): 1493 cmꢁ1, m.p.: 128e129 ꢀC. Anal. Calc. for
14H10N2Cl2: C, 60.67; H, 3.64; N, 10.11. Found: C, 60.62; H, 3.66; N:
10.18%. 1H NMR (399.9 MHz, CDCl3)
g
4.3.1. General procedure for the preparation of the half sandwich
ruthenium(II) complexes
C
d
(ppm) ¼ 8.15 (s, 1H, NCHN),
A solution of N-alkylbenzimidazole (1.0 mol) and [RuCl2(p-
cymene)]2 (0.5 mol) in 10 mL toluene was heated under reflux for
5 h. Upon cooling to room temperature, orange crystals of 1e6 were
obtained. The crystals were filtered off, washed with diethyl ether
(3 ꢂ 15 mL) and dried under vacuum.
7.90e7.85 (m, 1H, NC6H4N), 7.48e7.25 (m, 5H, NC6H4N and
CH2C6H3Cl2-3,4), 7.03e6.99 (m, 1H, NC6H4N), 5.37 (s, 2H,
CH2C6H3Cl2-3,4). 13C NMR (100.5 MHz, CDCl3)
(NCHN), 142.9, 135.6, 133.5, 133.4, 132.6, 131.1, 128.9, 126.2, 123.6,
122.8, 120.5109.9 (NC6H4N and CH2C6H3Cl2-3,4), 47.8 (CH2C6H3Cl2-
3,4).
d
(ppm) ¼ 143.4
4.3.1.1. Dichloro-(N-(3,4-dichlorobenzyl)benzimidazole)(p-cymene)
ruthenium(II), 1. Yield: 0.40 g (69%). FT-IR y(CN): 1507 cmꢁ1, m.p.:
232e233 ꢀC. Anal. Calc. for C24H24Cl4N2Ru: C, 49.41; H, 4.15; N, 4.80.
Found: C, 49.45; H, 4.12; N:4.76%. 1H NMR (399.9 MHz, CDCl3)
4.2.1.2. N-(4-Chlorobenzyl)benzimidazole, L2. Synthesis and char-
acterization data has been given by R.W. Hartmann [43].
d
(ppm) ¼ 8.42 (s, 1H, NCHN), 8.03 (d, 1H, J ¼ 8.4 Hz, NC6H4N), 7.36e
7.14 (m, 6H, NC6H4N and CH2C6H3Cl2-3,4), 5.55 (d, 2H, J ¼ 6.0 Hz,
(CH3)2CHC6H4CH3-4), 5.42 (d, 2H, J ¼ 6.0 Hz, (CH3)2CHC6H4CH3-4),
4.2.1.3. N-(4-Methoxybenzyl)benzimidazole, L3. Yield: 2.19 g (92%).
FT-IR y(CN): 1492 cmꢁ1, m.p.: 64e65 ꢀC. Anal. Calc. for C15H14N2O: C,
75.61; H, 5.92; N, 11.76. Found: C, 75.65; H, 5.90; N: 11.77%. 1H NMR
4.97 (s, 2H, CH2C6H3Cl2-3,4), 2.77 (hept., 1H,
J
¼
6.0 Hz,
(CH3)2CHC6H4CH3-4), 2.11 (s, 3H, (CH3)2CHC6H4CH3-4), 1.24 (d, 6H,
(399.9 MHz, CDCl3)
d
(ppm) ¼ 7.94 (s, 1H, NCHN), 7.87e7.82 (m, 1H,
J ¼ 6.9 Hz, (CH3)2CHC6H4CH3-4). 13C NMR (100.5 MHz, CDCl3)
NC6H4N), 7.35e7.23 (m, 3H, NC6H4N), 7.16 (d, 2H, J ¼ 11.1 Hz,
CH2C6H4(OCH3)-4), 6.89 (d, 2H, J ¼ 11.7 Hz, CH2C6H4(OCH3)-4), 5.30
(s, 2H, CH2C6H4(OCH3)-4), 3.80 (s, 3H, CH2C6H4(OCH3)-4). 13C NMR
d
(ppm) ¼ 144.9 (NCHN), 142.3, 135.4, 133.2, 133.0, 132.6, 131.0,
128.8, 127.2, 124.8, 123.4, 111.6 (NC6H4N and CH2C6H3Cl2-3,4), 102.4,
98.0, 83.1, 81.1 ((CH3)2CHC6H4CH3-4), 48.2 (CH2C6H3Cl2-3,4),
30.7 ((CH3)2CHC6H4CH3-4), 22.3 ((CH3)2CHC6H4CH3-4), 18.5
((CH3)2CHC6H4CH3-4).
(100.5 MHz, CDCl3)
128.7, 127.4, 123.0, 122.2, 120.4, 114.4, and 110.1(NC6H4N and
d
(ppm) ¼ 143.9 (NCHN), 159.6, 143.1, 133.9,
CH2C6H4(OCH3)-4),
(CH2C6H4(OCH3)-4).
55.3 (CH2C6H4(OCH3)-4), 48.5
4.3.1.2. Dichloro-(N-(4-chlorobenzyl)benzimidazole)-(p-cymene)
ruthenium(II), 2. Yield: 0.39 g (72%). FT-IR y(CN): 1509 cmꢁ1, m.p.:
228e229 ꢀC. Anal. Calc. for C24H25CI3N2Ru: C, 52.52; H, 4.59; N,
5.10. Found: C, 52.48; H, 4.62; N: 5.15%. 1H NMR (399.9 MHz, CDCl3)
4.2.1.4. N-(3,5-Ditert-butylbenzyl)benzimidazole, L4. Yield: 2.82 g
(88%). FT-IR y(CN): 1450 cmꢁ1, m.p.: 137e138 ꢀC. Anal. Calc.
for C22H28N2: C, 82.45; H, 8.81; N, 8.74. Found: C, 82.48; H,
8.83; N: 8.72%. 1H NMR (399.9 MHz, CDCl3)
d
(ppm) ¼ 7.97 (s,
d
(ppm) ¼ 8.45 (s, 1H, NCHN), 8.03 (d, 1H, J ¼ 7.8 Hz NC6H4N), 7.38e
1H, NCHN), 7.87e7.84 (m, 1H, NC6H4N), 7.41e7.28 (m, 4H,
NC6H4N and CH2C6H3(C(CH3)3)2)-3,5), 6.88e6.74 (m, 2H,
CH2C6H3(C(CH3)3)2-3,5), 5.36 (s, 2H, CH2C6H3(C(CH3)3)2-3,5),
1.30 (s, 18H, CH2C6H3(C(CH3)3)2)-3,5). 13C NMR (100.5 MHz,
7.25 (m, 3H, NC6H4N), 7.26 and 7.12 (d, 4H, J ¼ 8.4 Hz, CH2C6H4Cl-4),
5.55 (d, 2H, J ¼ 6.0 Hz (CH3)2CHC6H4CH3-4), 5.40 (d, 2H, J ¼ 6.0 Hz
(CH3)2CHC6H4CH3-4), 5.08 (s, 2H, CH2C6H4Cl-4), 2.81 (hep. 1H,
J ¼ 6.9 Hz, (CH3)2CHC6H4CH3-4), 2.1 (s, 3H, (CH3)2CHC6H4CH3-4),
1.24 (d, 6H, J ¼ 6.9 Hz, (CH3)2CHC6H4CH3-4). 13C NMR (100.5 MHz,
CDCl3)
d
(ppm) ¼ 143.7 (NCHN), 151.8, 143.0, 134.3, 134.1, 126.9,
123.0, 122.5, 122.4, 122.3, 121.7, 120.3, and 110.1(NC6H4N and
CH2C6H3(C(CH3)3)2)-3,5), 49.5 (CH2C6H3(C(CH3)3)2)-3,5), 34.9
(CH2C6H3(C(CH3)3)2)-3,5), 31.4 (CH2C6H3(C(CH3)3)2)-3,5).
CDCl3)
d
(ppm) ¼ 144.9 (NCHN), 142.5, 134.4, 133.5, 133.4, 129.2,
128.8, 124.5, 123.6, 120.5, 111.4 (NC6H4N and CH2C6H4Cl-4), 102.5,
97.8, 83.0, 81.1 ((CH3)2CHC6H4CH3-4), 48.7 (CH2C6H4Cl-4),